<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02489578</url>
  </required_header>
  <id_info>
    <org_study_id>NCT20150101</org_study_id>
    <nct_id>NCT02489578</nct_id>
  </id_info>
  <brief_title>A Retrospective Study on Hospitalized Patients With Community-acquired Pneumonia in China (CAP-China)</brief_title>
  <acronym>RSCAP-China</acronym>
  <official_title>Management in Real-life of Patients Hospitalized With Community-acquired Pneumonia in China</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Capital Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Beijing Chao Yang Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Jishuitan Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Luhe Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Qingdao Municipal Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Qilu Hospital of Shandong University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Huimin Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>China-Japan Friendship Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Linzi Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Second Hospital of Beijing Armed Police Corps</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kunming Yan'an Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Capital Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the disease burden of hospitalized patients with CAP
      and healthcare-associated pneumonia (HCAP) in real life of China .
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In China, the data about current management of patients hospitalized with CAP in the
      real-life setting is not available,type of pneumonia, selection of initial antibiotic, time
      to clinical stability, antibiotic choice anf modification,clinical outcomes and costs remain
      unclear.

      In this study, we will collect comprehensive information on CAP and HCAP management patterns
      to evaluate the disease burden of hospitalized patients with CAP and HCAP in real life of
      China .to analyze microbiological characteristics,clinical manifestations,antibiotic regimens
      ,adherences to guidelines and effect on outcome in different groups of patients with CAP (&gt;
      and = 65 years, different comorbidities ,risk factors) ,to investigate microbiological
      characteristics,clinical manifestations,antibiotic regimens ,adherences to guidelines and
      effect on outcome in different groups of disease severity with CAP ,to provide the difference
      on microbiological characteristics,clinical manifestations,antibiotic regimens ,and outcome
      between patients with CAP and HCAP ,to understand the current situation of antibiotic regimen
      ,to evaluate influence of different antibiotic regimens on prognosis.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2015</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>treatment failure at 72h after initiation of antibiotics</measure>
    <time_frame>Time from the first dose use of antibiotics to 72 hours</time_frame>
    <description>treatment failure was defined as a change of antibiotics due to worsening signs or symptoms associated with pneumonia</description>
  </primary_outcome>
  <primary_outcome>
    <measure>in-hospital treatment failure due to multiple causes</measure>
    <time_frame>Time from date of admission to discharge up to 1 week</time_frame>
    <description>1)death in hospital;2)change of antibiotics due to worsening signs or symptoms of infection, 3) recurrence, defined as signs or symptoms of infection after completion of therapy requiring re-initiation of antibiotics</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration of intravenous antimicrobial therapy</measure>
    <time_frame>2 weeks</time_frame>
    <description>Time from the first dose of intravenous antibiotics to date of stop of intravenous antibiotics ,participants will be followed for the duration of hospital stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital length of stay</measure>
    <time_frame>2 weeks</time_frame>
    <description>Patients will be asked about hospitalization, date, Patients will be asked about hospitalization, date, participants will be asked about the time of admission and discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>in-hospital mortality</measure>
    <time_frame>2 weeks</time_frame>
    <description>Time from date of admission to date of discharge,participants will be followed for the duration of hospital stay</description>
  </secondary_outcome>
  <enrollment type="Anticipated">3000</enrollment>
  <condition>Community Acquired Pneumonia</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>other</intervention_name>
    <description>retrospective cohort study</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        3000 patients with community acquired pneumonia who meet the below inclusion/ exclusion
        criteria will be recruited in China.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients &gt; or = 14 years of age

          -  Patient meets the criteria of community acquired pneumonia

          -  Patient meets the criteria of healthcare-associated pneumonia

        Exclusion Criteria:

          -  Patients &lt;14 years of age

          -  Patient meets the criteria of hospital acquired pneumonia

          -  Known active tuberculosis or current treatment for tuberculosis

          -  Non-infectious pulmonary diseases

          -  HIV positive
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bin Cao, MD</last_name>
    <role>Study Chair</role>
    <affiliation>China-Japan Friendship Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Bin Cao, MD</last_name>
    <phone>86-010-84206264</phone>
    <email>caobin_ben@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>LI Gu, MD</last_name>
    <phone>86-010-85231514</phone>
    <email>guli2013227@foxmail.com.cn</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>China-Japan Friendship Hospital</name>
      <address>
        <city>Beijing</city>
        <zip>100029</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bin Cao, MD</last_name>
      <phone>86-010-84206264</phone>
      <email>caobin_ben@163.com</email>
    </contact>
    <contact_backup>
      <last_name>Li Gu, MD</last_name>
      <phone>86-010-85231514</phone>
      <email>guli2013227@foxmail.com.cn</email>
    </contact_backup>
    <investigator>
      <last_name>Bin cao, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed/?term=Influenza+pneumonia+among+adolescents+and+adults%3A+a+concurrent+comparison+between+influenza+A+(H1N1)+pdm09+and+A+(H3N2)+in+the+post-pandemic+period.</url>
  </link>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed/?term=Emergence+of+community-acquired+adenovirus+type+55+as+a+cause+of+community-onset+pneumonia</url>
  </link>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed/?term=Accuracy+of+IgM+antibody+testing%2C+FQ-PCR+and+culture+in+laboratory+diagnosis+of+acute+infection+by+Mycoplasma+pneumoniae+in+adults+and+adolescents+with+community-acquired+pneumonia.</url>
  </link>
  <results_reference>
    <citation>Yang SQ, Qu JX, Wang C, Yu XM, Liu YM, Cao B. Influenza pneumonia among adolescents and adults: a concurrent comparison between influenza A (H1N1) pdm09 and A (H3N2) in the post-pandemic period. Clin Respir J. 2014 Apr;8(2):185-91. doi: 10.1111/crj.12056. Epub 2013 Nov 26.</citation>
    <PMID>24106842</PMID>
  </results_reference>
  <results_reference>
    <citation>Cao B, Huang GH, Pu ZH, Qu JX, Yu XM, Zhu Z, Dong JP, Gao Y, Zhang YX, Li XH, Liu JH, Wang H, Xu Q, Li H, Xu W, Wang C. Emergence of community-acquired adenovirus type 55 as a cause of community-onset pneumonia. Chest. 2014 Jan;145(1):79-86. doi: 10.1378/chest.13-1186.</citation>
    <PMID>24551881</PMID>
  </results_reference>
  <results_reference>
    <citation>Qu J, Gu L, Wu J, Dong J, Pu Z, Gao Y, Hu M, Zhang Y, Gao F, Cao B, Wang C; Beijing Network for Adult Community-Acquired Pneumonia (BNACAP). Accuracy of IgM antibody testing, FQ-PCR and culture in laboratory diagnosis of acute infection by Mycoplasma pneumoniae in adults and adolescents with community-acquired pneumonia. BMC Infect Dis. 2013 Apr 11;13:172. doi: 10.1186/1471-2334-13-172.</citation>
    <PMID>23578215</PMID>
  </results_reference>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 16, 2015</study_first_submitted>
  <study_first_submitted_qc>July 1, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 3, 2015</study_first_posted>
  <last_update_submitted>October 14, 2015</last_update_submitted>
  <last_update_submitted_qc>October 14, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 16, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Capital Medical University</investigator_affiliation>
    <investigator_full_name>Bin Cao</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Community Acquired Pneumonia</keyword>
  <keyword>health care associated pneumonia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumonia</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>April 25, 2016</submitted>
    <submission_canceled>Unknown</submission_canceled>
    <submitted>May 7, 2016</submitted>
    <returned>June 13, 2016</returned>
    <submitted>June 20, 2016</submitted>
    <returned>August 1, 2016</returned>
    <submitted>November 11, 2016</submitted>
    <returned>January 9, 2017</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

